The combination of ANGPTL6 with AFP provided better diagnostic performance of preclinical HCC before clinical diagnosis (AUC 0.852, sensitivity 72.7%, specificity 87.5%, Fig. 7c). The gene discussed is AFP; the disease is hepatocellular carcinoma.